Seres Therapeutics (MCRB) Misses Q3 EPS by 6c
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.